Benefit-Cost Analysis

Factoring Equity into Benefit-Cost Analysis

Factoring Equity into Benefit-Cost Analysis

Distributional weighting shows how benefit-cost analysis can be improved.

Flipping the Mission of Regulatory Review

Flipping the Mission of Regulatory Review

President Biden’s memo could transform the mission of regulatory review by expanding OIRA’s role.

Regulatory Review Reimagined

Regulatory Review Reimagined

Scholars discuss President Biden’s executive order that seeks to modernize the regulatory review process.

Recognizing the Losers in Benefit-Cost Analysis

Recognizing the Losers in Benefit-Cost Analysis

Policymakers should consider direct compensation for people who regulations negatively affect.

A Decade of Political Swings, and Consistency

A Decade of Political Swings, and Consistency

Presidential administrations have taken dramatically different approaches to regulation over the last ten years.

Analyzing COVID-19 Policymaking

Analyzing COVID-19 Policymaking

Experts assess the use of VSLs and benefit-cost analysis for pandemic decision-making.

COVID-19 and Uncertainties in the Value Per Statistical Life

COVID-19 and Uncertainties in the Value Per Statistical Life

Uncertainties in value per statistical life estimates impact the extent to which COVID-19 policies yield net benefits.

Rethinking Benefit-Cost Analysis for COVID-19

Rethinking Benefit-Cost Analysis for COVID-19

The normative foundations of the value of statistical life render it an insufficient tool to analyze pandemic-related policies.